Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrick T Harrison

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Current Opinion in Pharmacology|November 7, 2017
Genetic therapies for cystic fibrosis lung diseaseStephen L Hart, Patrick T Harrison
Bio-Protocol|March 3, 2021
Minigene assay to Evaluate CRISPR/Cas9-based excision of Intronic mutations that Cause Aberrant Splicing in Human CellsDavid J Sanz, Patrick T Harrison
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2017
Gene editing & stem cellsPatrick T Harrison, Nils Hoppe, Ulrich Martin
Genes|May 24, 2019
Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis-Learning from Other DiseasesKaren Mention, Lúcia Santos, Patrick T Harrison
Gene Therapy|November 28, 2024
Prime editing: therapeutic advances and mechanistic insightsJoss B Murray, Patrick T Harrison, Janine Scholefield
Human Genetics|June 22, 2016
Impact of gene editing on the study of cystic fibrosisPatrick T Harrison, David J Sanz, Jennifer A Hollywood
Journal of Neural Transmission (Vienna, Austria : 1996)|March 30, 2010
Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivoDavid B O'Sullivan, Patrick T Harrison, Aideen M Sullivan
Pathogens (Basel, Switzerland)|July 26, 2020
Polycystic Kidney Disease Ryanodine Receptor Domain (PKDRR) Proteins in OomycetesLimian Zheng, Barbara Doyle Prestwich, Patrick T Harrison, et al.
Scientific Reports|August 26, 2016
Analysis of gene repair tracts from Cas9/gRNA double-stranded breaks in the human CFTR geneJennifer A Hollywood, Ciaran M Lee, Martina F Scallan, et al.
Cells|January 11, 2022
In Vitro and In Vivo Models to Study Nephropathic CystinosisPang Yuk Cheung, Patrick T Harrison, Alan J Davidson, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Current Opinion in Pharmacology|November 7, 2017
Genetic therapies for cystic fibrosis lung diseaseStephen L Hart, Patrick T Harrison
Bio-Protocol|March 3, 2021
Minigene assay to Evaluate CRISPR/Cas9-based excision of Intronic mutations that Cause Aberrant Splicing in Human CellsDavid J Sanz, Patrick T Harrison
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|December 14, 2017
Gene editing & stem cellsPatrick T Harrison, Nils Hoppe, Ulrich Martin
Genes|May 24, 2019
Gene and Base Editing as a Therapeutic Option for Cystic Fibrosis-Learning from Other DiseasesKaren Mention, Lúcia Santos, Patrick T Harrison
Gene Therapy|November 28, 2024
Prime editing: therapeutic advances and mechanistic insightsJoss B Murray, Patrick T Harrison, Janine Scholefield
Human Genetics|June 22, 2016
Impact of gene editing on the study of cystic fibrosisPatrick T Harrison, David J Sanz, Jennifer A Hollywood
Journal of Neural Transmission (Vienna, Austria : 1996)|March 30, 2010
Effects of GDF5 overexpression on embryonic rat dopaminergic neurones in vitro and in vivoDavid B O'Sullivan, Patrick T Harrison, Aideen M Sullivan
Pathogens (Basel, Switzerland)|July 26, 2020
Polycystic Kidney Disease Ryanodine Receptor Domain (PKDRR) Proteins in OomycetesLimian Zheng, Barbara Doyle Prestwich, Patrick T Harrison, et al.
Scientific Reports|August 26, 2016
Analysis of gene repair tracts from Cas9/gRNA double-stranded breaks in the human CFTR geneJennifer A Hollywood, Ciaran M Lee, Martina F Scallan, et al.
Cells|January 11, 2022
In Vitro and In Vivo Models to Study Nephropathic CystinosisPang Yuk Cheung, Patrick T Harrison, Alan J Davidson, et al.
Pageof 4